RESEARCH BASE

Search 3,721 documents across 34 fields — every claim tier-rated by evidence

3,721 Documents 34 Sections 43,625 Citations 34,852 Keywords Indexed 4 Evidence Tiers

3,633 are the core, quality-scored corpus (34 lettered sections — see How We Work); the remaining 88 are cross-corpus synthesis documents (68 InterDocs, 12 Connections, 8 Theories) also indexed here.

2,448 results for "Shang Di" — page 9 of 123

Z_5_10 Verified Molecular Biology

Z_5_10 — Genome Editing Beyond CRISPR: TALENs, Base Editors, Prime Editors, and Next-Generation Tools

While CRISPR-Cas9 (covered in Z_1_02) dominates the genome editing landscape, it is neither the first nor the only precision genome editing technology. The field began with zinc finger nucleases (ZFNs) in the early 2000s

genome editing TALENs zinc finger nucleases ZFN base editing prime editing
Z_5_08 Verified Molecular Biology

Z_5_08 — Mitochondrial DNA: Maternal Inheritance, Ancient Lineages, and Disease

Mitochondrial DNA (mtDNA) — the small, circular genome (~16,569 base pairs in humans) contained within mitochondria — encodes 37 genes essential for oxidative phosphorylation (13 protein-coding genes, 22 transfer RNAs, 2

mitochondrial DNA mtDNA maternal inheritance mitochondrial Eve heteroplasmy oxidative phosphorylation
Z_3_06 Verified Molecular Biology

Z_3_06 — Genetics of Circadian Rhythms

Circadian rhythms — endogenous ~24-hour oscillations in physiology and behavior — are generated by an intracellular transcription-translation feedback loop (TTFL) encoded by a set of core clock genes conserved across ani

circadian rhythm clock genes CLOCK BMAL1 PER CRY
Z_2_15 Verified Molecular Biology

Z_2_15 — Future of Genomics and Personalized Medicine

Genomics is undergoing a transition from research tool to clinical infrastructure. The cost of whole-genome sequencing (WGS) has plummeted from $2.7 billion (Human Genome Project, 1990–2003) to ~$200 per genome (Illumina

future genomics personalized medicine precision medicine polygenic risk scores whole genome sequencing newborn screening
Z_2_13 Verified Molecular Biology

Z_2_13 — Pharmacogenomics and Personalized Medicine

Pharmacogenomics — the study of how genetic variation influences drug response — is among the most clinically actionable applications of human genetics. Adverse drug reactions (ADRs) are the 4th–6th leading cause of deat

pharmacogenomics pharmacogenetics personalized medicine precision medicine CYP2D6 CYP2C_5_04
Z_2_17 Verified Molecular Biology

Z_2_17 — Prion Biology: Self-Propagating Protein Misfolding and Transmissible Encephalopathies

Prions — proteinaceous infectious particles lacking nucleic acid — represent a paradigm-shattering departure from the central dogma that biological information flows from DNA to RNA to protein. The protein-only hypothesi

prion PrPSc PrPC transmissible spongiform encephalopathy Stanley Prusiner mad cow disease
Z_2_18 Verified Molecular Biology

Z_2_18 — Pharmacogenomics and Precision Medicine

Pharmacogenomics — the study of how genetic variation affects individual responses to drugs — aims to replace the "one-size-fits-all" prescribing model with genotype-guided therapy, selecting the right drug at the right

pharmacogenomics precision-medicine drug-metabolism cyp450 warfarin adverse-drug-reactions
Z_2_09 Verified Molecular Biology

Z_2_09 — Mitochondrial Genetics and Diseases

Human mitochondrial DNA (mtDNA) is a 16,569-bp circular genome encoding 37 genes: 13 proteins (all subunits of the oxidative phosphorylation/OXPHOS complexes I, III, IV, and V), 22 transfer RNAs, and 2 ribosomal RNAs. Un

mitochondrial genetics mtDNA mitochondrial DNA mitochondrial disease oxidative phosphorylation OXPHOS
Z_2_04 Verified Molecular Biology

Z_2_04 — Genetic Disorders and Inborn Errors of Metabolism

Genetic disorders — diseases caused by mutations in single genes (monogenic) or chromosomal abnormalities — affect ~3–5% of live births and collectively represent thousands of distinct conditions catalogued in the Online

genetic disorder inborn error metabolism Mendelian disease sickle cell cystic fibrosis
Z_2_06 Credible Molecular Biology

Z_2_06 — Nutrigenomics and Diet-Gene Interactions

Nutrigenomics — the study of how genetic variation influences nutritional requirements, dietary responses, and disease susceptibility — and its complement nutrigenetics (how diet influences gene expression) represent a r

nutrigenomics nutrigenetics diet-gene interaction lactase persistence alcohol metabolism folate metabolism
Z_2_11 Verified Molecular Biology

Z_2_11 — Genetics of Immunity and MHC Diversity

The major histocompatibility complex (MHC) — known as the human leukocyte antigen (HLA) system in humans — is the most polymorphic gene region in the human genome, encoding cell-surface glycoproteins essential for adapti

major histocompatibility complex MHC HLA human leukocyte antigen adaptive immunity antigen presentation
Z_2_07 Verified Molecular Biology

Z_2_07 — Genetics of Disease Resistance

Infectious disease has been the most powerful selective force shaping the human genome, leaving signatures across thousands of loci. The best-understood example is sickle cell disease (HbS, Glu6Val in HBB): heterozygous

disease resistance natural selection pathogen-driven selection sickle cell malaria resistance HbS
Z_1_19 Verified Molecular Biology

Z_1_19 — Non-Coding RNA and Gene Regulation

Non-coding RNAs (ncRNAs) — RNA molecules that are transcribed from the genome but do not encode proteins — have emerged as central regulators of gene expression, challenging the classical "one gene–one protein" paradigm

non-coding-rna microrna lncrna gene-regulation rna-interference sirna
Z_4_18 Verified Molecular Biology

Z_4_18 — Protein Misfolding and Prion Diseases

Prion diseases — transmissible spongiform encephalopathies (TSEs) — are fatal neurodegenerative disorders caused by the misfolding and self-propagating aggregation of a normal cellular protein (PrPᶜ) into a pathological

prion protein-misfolding amyloid bse cjd mad-cow-disease
Z_4_17 Verified Molecular Biology

Z_4_17 — Non-coding RNA Networks: Regulation Beyond the Genome

Non-coding RNAs (ncRNAs) — RNA molecules that are not translated into protein but perform functional roles in the cell — have emerged since the late 1990s as a vast and previously unsuspected layer of biological regulati

non-coding RNA microRNA lncRNA RNA interference gene regulation RNA world
K_3_14 Credible Consciousness

K_3_14 — Consciousness in Octopuses and Distributed Nervous Systems

Octopuses (Octopus vulgaris, O. bimaculoides, Abdopus aculeatus, and ~300 other species in order Octopoda) represent perhaps the most profound natural experiment in the evolution of consciousness: they are the most cogni

octopus cephalopod consciousness distributed nervous system invertebrate cognition mollusc
K_4_12 Credible Consciousness

K_4_12 — Noosphere — Teilhard de Chardin, Vernadsky, and the Thinking Layer

The noosphere ("sphere of mind") is a concept developed independently by Russian geochemist Vladimir Vernadsky and French paleontologist-priest Pierre Teilhard de Chardin in the 1920s, describing a layer of collective hu

noosphere Teilhard de Chardin Vernadsky Omega Point Édouard Le Roy collective consciousness
K_2_18 Verified Consciousness

K_2_18 — Meditation Neurophysiology

Neuroimaging studies of meditation have produced a convergent picture: focused attention practices increase prefrontal and anterior cingulate cortex activity, open monitoring practices decrease default mode network (DMN)

meditation-neurophysiology fmri-meditation eeg-correlates default-mode-network mindfulness-neuroscience long-term-meditators
K_2_20 Verified Consciousness

K_2_20 — Savant Syndrome — Neuroscience of Extraordinary Ability

Savant syndrome — the coexistence of extraordinary ability in a specific domain with significant cognitive disability or neurodevelopmental condition — was first described medically by J. Langdon Down (the physician who

savant syndrome savant extraordinary ability autism intellectual disability prodigious savant
K_5_11 Credible Consciousness

K_5_11 — Synaesthesia and Consciousness: Cross-Modal Binding

Synaesthesia (British spelling; "synesthesia" in American English) is a neurological condition in which stimulation of one sensory or cognitive pathway automatically triggers an involuntary experience in a second, unstim

synaesthesia synesthesia cross-modal grapheme-color sound-color chromesthesia